Skip to main content

Gilead Joining the Global Access to Oncology Medicines Coalition

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

We’re pleased to announce that we're joining the global Access to Oncology Medicines (ATOM) Coalition to help improve care and access to essential cancer medicines in low- and lower middle-income countries. https://gilead.inc/39Gb9nb

About Gilead

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View original content here

Tweet me: .@GileadSciences announces they are joining the global Access to Oncology Medicines (ATOM) Coalition. Read more here: https://bit.ly/3PHkf3F

KEYWORDS: NYSE: GILD, Gilead Sciences, ATOM

"Making strides against cancer in low- and lower middle- income countries will require not only innovative therapies, but also bold strategies built on the power of partnerships and working across the continuum of care - starting from disease awareness and prevention, to diagnosis and treatment, all the way to disease management." Mike Boyd Senior Vice President Gilead logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  247.38
+1.09 (0.44%)
AAPL  259.37
+0.33 (0.13%)
AMD  203.17
-1.51 (-0.74%)
BAC  55.85
-0.33 (-0.59%)
GOOG  329.14
+3.13 (0.96%)
META  653.06
+7.00 (1.08%)
MSFT  479.28
+1.17 (0.24%)
NVDA  184.86
-0.18 (-0.10%)
ORCL  198.52
+9.37 (4.95%)
TSLA  445.01
+9.21 (2.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.